Inactive Instrument
Cann American Corp. Stock Other OTC
Stocks
CNNA
US13764N2071
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.77M 1.55M 1.43M 1.32M 2.5M 169M 2.55M 17.07M 6.7M 83.2M 6.65M 6.5M 286M | P/E 2022 |
0.12x | P/E 2023 | 0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 2.08M 1.82M 1.68M 1.55M 2.94M 199M 2.99M 20.07M 7.88M 97.82M 7.82M 7.65M 336M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
99% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +4.97% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Tucker
BRD | Director/Board Member | - | 2023-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.97% | +24.45% | - | - | 4.94M | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -0.56% | -3.25% | +26.72% | +56.70% | 397.1B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | 10.54M 9.22M 8.5M 7.85M 14.9M 1.01B 15.16M 102M 39.91M 495M 39.58M 38.72M 1.7B | 3.82M 3.34M 3.08M 2.85M 5.4M 364M 5.49M 36.84M 14.47M 180M 14.35M 14.04M 617M |
| Net Debt | 202K 177K 163K 150K 285K 19.25M 290K 1.95M 764K 9.48M 758K 741K 32.6M | 311K 272K 251K 232K 440K 29.67M 447K 3M 1.18M 14.62M 1.17M 1.14M 50.25M |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
